0000891293-22-000044.txt : 20220816
0000891293-22-000044.hdr.sgml : 20220816
20220816160758
ACCESSION NUMBER: 0000891293-22-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Craig Adam R
CENTRAL INDEX KEY: 0001339498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28386
FILM NUMBER: 221170249
MAIL ADDRESS:
STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC.
STREET 2: 555 MADISON AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-08-16
0
0000891293
CTI BIOPHARMA CORP
CTIC
0001339498
Craig Adam R
3101 WESTERN AVENUE
SUITE 800
SEATTLE
WA
98121
1
1
0
0
President and CEO
common stock
2022-08-16
2022-08-16
4
P
0
5000
5.5
A
27861
D
Adam R. Craig
2022-08-16